Exclusive Content
Roche secures deal to acquire LumiraDx’s Point of Care technology for USD 295 million
Roche has revealed plans to acquire specific sections of LumiraDx, focusing on their innovative Point of Care technology. This move, expected to be finalised...
Researchers Discover Promising Antibiotic in Human Nose
In a seminal discovery, researchers at the University of Tübingen have revealed a potential paradigm shift in antibiotic development with the identification of a...
Researchers Argue for Enhanced Farm Animal Conditions
A recent examination by researchers from the University of Winchester (U.K.) and Griffith University (Australia) delves into the perils associated with keeping chickens and...
Breakthrough for Dry Eyes: Alcon’s therapy shines in final tests
Millions struggle with dry, gritty eyes, a condition called dry eye disease (DED). It's a nuisance at best, and a debilitating struggle at worst....
Protecting the next generation: Valneva aims chikungunya with vaccine for young ones
A crucial step has been taken towards protecting children from chikungunya, a mosquito-borne disease causing debilitating joint pain and fever. Valneva, a vaccine company,...
New weapon against cervical cancer: US greenlights Pfizer trial
In a promising development for patients battling advanced cervical cancer, a targeted therapy called Tivdak is moving closer to full approval in the US....